Literature DB >> 8729885

Lorazepam stability in parenteral solutions for continuous intravenous administration.

L L Hoey1, K Vance-Bryan, D M Clarens, D H Wright, F N Konstantinides, D R Guay.   

Abstract

OBJECTIVE: To determine the stability of lorazepam over a 24-hour period when prepared in polyvinyl chloride (PVC) bags at initial concentrations of 0.08 and 0.5 mg/mL.
DESIGN: Each concentration was studied at room (21 degrees C) and refrigerator (4 degrees C) temperatures in dextrose 5% (D5W) and NaCl 0.9% solutions. Duplicate test solution admixtures were prepared for each lorazepam concentration, diluent, and temperature. At 0, 1, 4, 8, and 24 hours, duplicate samples were obtained for visual inspection, pH determination, and concentration determination by stability-indicating, reverse-phase HPLC analysis. Compared with baseline, peaks for lorazepam degradation products were not found on any of the study chromatograms.
RESULTS: In D5W and NaCl 0.9% solutions, lorazepam loss in excess of 10% by HPLC analysis occurred for concentrations of 0.08 and 0.5 mg/mL at 1 and 4 hours, respectively.
CONCLUSIONS: These data suggest that significant loss of lorazepam occurs as the probable result of sorption to PVC bags when admixed in both D5W and NaCl 0.9% solutions at 21 and 4 degrees C.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8729885     DOI: 10.1177/106002809603000403

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  1 in total

1.  Long-Term Stability of Lorazepam in Sodium Chloride 0.9% Stored at Different Temperatures in Different Containers.

Authors:  M L Colsoul; A Breuer; N Goderniaux; J D Hecq; L Soumoy; B Bihin; J Jamart; L Galanti
Journal:  Hosp Pharm       Date:  2019-03-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.